Berger & Montague Cases

Berger & Montague, as co-lead counsel, obtained a recovery of $475 million in 2009 for the benefit of the class in one of the largest recoveries among the recent financial crisis cases. (Civil Action No. 07-CV-09633 (S.D.N.Y.)).

Berger & Montague, as one of four
court-appointed Co-Lead Counsel, recovered more than $15
million in settlements for the benefit of direct purchasers of
methyl methacrylate ("MMA") and acrylic
products.
Defendants were the leading manufacturers of...

Berger & Montague was one of two Co-Lead counsel in the case on behalf of a class of wholesalers and pharmacies, alleging that AztraZeneca used a fraudulently obtained patent to block the entry of lower priced generic competitors to their brand-name prescription medication, sold under the brand name Toprol XL. The suit alleged that the anticompetitive conduct forced all purchasers to overpay for this prescription medication.

On May 21, 2012, Berger & Montague was named co-lead counsel
in this litigation. A copy of the judge's order is available
for download here.
On January 10, 2012, Berger & Montague filed a class action
complaint on behalf of tens of thousands...

As court-appointed liaison counsel, the firm was one of four
lead counsel who structured the $1.3 billion "global" settlement of
all claims pending against Michael R. Milken, over 200 present and
former officers and directors of Drexel Burnham Lambert,...

Berger & Montague represented a class of over five thousand non-exempt hourly production, maintenance and sanitation employees at Indiana Packer's Delphi, Indiana facility. The complaint alleged that Indiana Packers did not pay its employees for all required pre-production line and post-production line activities that were necessary and integral to their overall employment responsibilities. These tasks include donning and doffing required safety gear and protective equipment, cleaning and sanitizing their equipment, walking to their lockers or production line after performing compensable activities, and waiting in line to receive required tools and equipment.

Berger & Montague, as one of two court
appointed Co-Lead Counsel, recovered $50 million in settlements for
the benefit of direct purchasers of microcrystalline cellulose
("MCC"), which is used as a binder in the production of
pharmaceuticals,...

The firm served as lead counsel and obtained a settlement of
$3.5 million on behalf of a group of African American employees of
Sara Lee Foods Corp. to resolve charges of racial discrimination
and retaliation at its Ball Park Franks plant.

The firm served as Lead Counsel for a class of investors in
Scudder/Deutsche Bank/ mutual funds in the nationwide Mutual Funds
Market Timing cases. These cases recovered over $300 million
for mutual fund purchasers and holders against various...

Through the firm's co-lead counsel role, cases against German
industry and banks for the use of slave and forced labor during the
Nazi era were ultimately settled in the context of international
negotiations which created a fund for victims of $4.5...

Berger & Montague obtained a $190 million
settlement on behalf of a class of direct purchasers of the
brand-name prescription drug Neurontin.
The Neurontin class alleged that Pfizer, Inc., one of the
nation's largest pharmaceutical...

The law office of Berger & Montague, P.C. filed a class action lawsuit against Nissan North America for the malfunction of the Continuously Variable Transmission (“CVT”) in Nissan’s 2013 and 2014 Pathfinder vehicles.

Berger & Montague obtained a $52 million
settlement for a class of direct purchasers of the anti-AIDS
medicines Norvir and Kaletra. Norvir serves as a "booster" to
prolong the efficacy of other anti-AIDS drugs.
Berger & Montague, as co-lead...

Berger & Montague is co-lead counsel for the class in the
Nuvelo Securities Litigation. The consolidated
complaint alleges, among other things, that defendants misled
investors by repeatedly trumpeting prior clinical success in the
ongoing clinical...

Berger & Montague is pleased to inform shareholders who invested in certain municipal bond funds managed by OppenheimerFunds, Inc. and distributed by OppenheimerFunds Distributor, Inc. that the Lead Plaintiffs in six consolidated class action lawsuits have reached an $85.9 million settlement with OppenheimerFunds, Inc. and other Defendants.

Berger & Montague, P.C., together with co-counsel,
prosecuted this class action against Anthem, Inc. (now known as
WellPoint, Inc.) and Anthem Insurance Companies, Inc., in the
United States District Court for the Southern District of Indiana...

Berger & Montague was among the lead class
counsel in this antitrust class action on behalf of direct
purchasers of the oral birth control medication, Ovcon
35.
The class accused the defendants Warner Chilcott and Barr
Pharmaceuticals of entering...

Berger & Montague represented a class of approximately 270 current and former California employees working as Installers who alleged they were not paid for the all time they worked, were denied meal periods and were not reimbursed for business expenses by their employer, U.S. Remodelers, Inc. The suit alleged U.S. Remodelers violated the California Labor Code and California Industrial Welfare Commission Wage Orders.